Literature DB >> 28138420

Care of the Elderly Patient on Oral Oncolytics for Advanced Disease.

Charles W Given1, Barbara A Given2.   

Abstract

Oral oncolytics are now a common component of cancer care for older individuals with advanced cancer when a new treatment regimen is needed. Many of the solid tumors in elderly patients may respond to the oral oncolytics, however not without side effects and challenges to maintain adherence. This article describes some of the important areas to be considered when oral oncolytics are prescribed for elderly patients. A general overview of important intervention areas of focus is included.

Entities:  

Keywords:  Geriatrics; cancer patient; medications; oral oncolytics

Year:  2016        PMID： 28138420      PMCID： PMC5271331          DOI： 10.1007/s13670-016-0183-8

Source DB:  PubMed          Journal:  Curr Geriatr Rep        ISSN： 2196-7865


  23 in total

Review 1.  Adherence enhancing interventions for oral anticancer agents: a systematic review.

Authors:  Tim Mathes; Sunya-Lee Antoine; Dawid Pieper; Michaela Eikermann
Journal:  Cancer Treat Rev       Date:  2013-08-01       Impact factor: 12.111

2.  Physician-pharmacist collaboration for oral chemotherapy monitoring: Insights from an academic genitourinary oncology practice.

Authors:  Lisa M Holle; Sonam Puri; Jessica M Clement
Journal:  J Oncol Pharm Pract       Date:  2015-04-21       Impact factor: 1.809

3.  In-office dispensing of oral oncolytics: a continuity of care and cost mitigation model for cancer patients.

Authors:  Nancy J Egerton
Journal:  Am J Manag Care       Date:  2016-03       Impact factor: 2.229

Review 4.  Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG).

Authors:  Martine Extermann; Matti Aapro; Roberto Bernabei; Harvey Jay Cohen; Jean-Pierre Droz; Stuart Lichtman; Vincent Mor; Silvio Monfardini; Lazzaro Repetto; Liv Sørbye; Eva Topinkova
Journal:  Crit Rev Oncol Hematol       Date:  2005-09       Impact factor: 6.312

5.  Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study.

Authors:  Arti Hurria; Carol Rosen; Clifford Hudis; Enid Zuckerman; Katherine S Panageas; Mark S Lachs; Matthew Witmer; Wilfred G van Gorp; Monica Fornier; Gabriella D'Andrea; Mark Moasser; Chau Dang; Catherine Van Poznak; Anju Hurria; Jimmie Holland
Journal:  J Am Geriatr Soc       Date:  2006-06       Impact factor: 5.562

Review 6.  Kinase inhibitors and monoclonal antibodies in oncology: clinical implications.

Authors:  Helen Gharwan; Hunter Groninger
Journal:  Nat Rev Clin Oncol       Date:  2015-12-31       Impact factor: 66.675

Review 7.  Cognitive dysfunctions in elderly cancer patients: a new challenge for oncologists.

Authors:  Marie Lange; Olivier Rigal; Bénédicte Clarisse; Bénédicte Giffard; Emmanuel Sevin; Marie Barillet; Francis Eustache; Florence Joly
Journal:  Cancer Treat Rev       Date:  2014-03-20       Impact factor: 12.111

Review 8.  Factors influencing adherence to cancer treatment in older adults with cancer: a systematic review.

Authors:  M T E Puts; H A Tu; A Tourangeau; D Howell; M Fitch; E Springall; S M H Alibhai
Journal:  Ann Oncol       Date:  2013-11-26       Impact factor: 32.976

9.  The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience.

Authors:  S Yousuf Zafar; Jeffrey M Peppercorn; Deborah Schrag; Donald H Taylor; Amy M Goetzinger; Xiaoyin Zhong; Amy P Abernethy
Journal:  Oncologist       Date:  2013-02-26

10.  The impact of cognitive function on medication management: three studies.

Authors:  Carol S Stilley; Catherine M Bender; Jacqueline Dunbar-Jacob; Susan Sereika; Christopher M Ryan
Journal:  Health Psychol       Date:  2010-01       Impact factor: 4.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.